Author:
Perlova Olena,Gerth Klaus,Kuhlmann Silvia,Zhang Youming,Müller Rolf
Abstract
Abstract
Although many secondary metabolites with diverse biological activities have been isolated from myxobacteria, most strains of these biotechnologically important gliding prokaryotes remain difficult to handle genetically. In this study we describe the new fast growing myxobacterial thermophilic isolate GT-2 as a heterologous host for the expression of natural product biosynthetic pathways isolated from other myxobacteria. According to the results of sequence analysis of the 16S rDNA, this moderately thermophilic isolate is closely related to Corallococcus macrosporus and was therefore named C. macrosporus GT-2. Fast growth of moderately thermophilic strains results in shorter fermentation and generation times, aspects which are of significant interest for molecular biological work as well as production of secondary metabolites. Development of a genetic manipulation system allowed the introduction of the complete myxochromide biosynthetic gene cluster, located on a transposable fragment, into the chromosome of GT-2. Genetic engineering of the biosynthetic gene cluster by promoter exchange leads to much higher production of myxochromides in the heterologous host C. macrosporus GT-2 in comparison to the original producer Stigmatella aurantiaca and to the previously described heterologous host Pseudomonas putida (600 mg/L versus 8 mg/L and 40 mg/L, respectively).
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference44 articles.
1. Sipahi OR: Economics of antibiotic resistance. Expert Review of Anti-Infective Therapy. 2008, 6: 523-539. 10.1586/14787210.6.4.523.
2. Reichenbach H, Höfle G: Myxobacteria as producers of secondary metabolites. Drug Discovery from Nature. Edited by: Grabley S, Thiericke R. 1999, 149-179. Berlin: Springer
3. Gerth K, Pradella S, Perlova O, Beyer S, Müller R: Myxobacteria: Proficient producers of novel natural products with various biological activities – past and future biotechnological aspects with the focus on the genus Sorangium. J Biotechnol. 2003, 106: 233-253. 10.1016/j.jbiotec.2003.07.015.
4. Höfle G, Reichenbach H: Epothilone, a myxobacterial metabolite with promising antitumor activity. Anticancer agents from natural products. Edited by: Cragg GM, Kingston DG, Newman DJ. 2005, 413-450. Boca Raton: Taylor & Francis
5. Sasse F, Steinmetz H, Heil J, Höfle G, Reichenbach H: Tubulysins, new cytostatic peptides from myxobacteria acting on microtubuli: Production, isolation, physico-chemical and biological properties. J Antibiot. 2000, 53: 879-885.
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献